English
新闻公告
More
化学进展 2009, Vol. 21 Issue (01): 100-105 前一篇   后一篇

• 中药研究专刊 •

关于中药质量控制与体内代谢研究的思考

叶敏;果德安*   

  1. (北京大学药学院 北京 100191)
  • 收稿日期:2008-04-28 修回日期:2008-10-22 出版日期:2009-01-24 发布日期:2009-01-25
  • 通讯作者: 果德安 E-mail:gda@bjmu.edu.cn

Strategies on the Quality Control and DMPK Studies of Traditional Chinese Medicine

Ye Min; Guo Dean*   

  1. (School of Pharmaceutical Sciences, Peking University, Beijing 100191, China)
  • Received:2008-04-28 Revised:2008-10-22 Online:2009-01-24 Published:2009-01-25
  • Contact: Guo Dean E-mail:gda@bjmu.edu.cn

质量控制是保证中药安全、有效的重要基础。体内代谢研究可以为阐明中药的治病机制提供依据。本文以蟾酥为例,讨论了当前中药质量控制及体内代谢研究存在的主要问题和解决办法:认为把中药指纹图谱的全面指认与多指标成分定量相结合是有效控制中药质量的可行途径;液相色谱2质谱联用技术(LCPMS) 将在中药化学研究、体内代谢研究等方面发挥重要作用;中药的化学指纹图谱应与药理活性相关联,从而建立合理的中药质量评价体系;结构修饰对基于天然产物的新药发现具有重要意义。

Quality control is critically important for the safety and efficacy of traditional Chinese medicine. DMPK (drug metabolism and pharmacokinetic) studies facilitate the clarification of the mechanism of action of traditional Chinese medicine. In this paper , we discuss the current barriers in the quality control and DMPK studies of traditional Chinese medicine by using our studies on toad venom (Chan-Su) as example. It is concluded that the combination of full assignments of the chemical fingerprint and the simultaneous quantitation of multiple compounds is a feasible way for the comprehensive quality control of traditional Chinese medicines. Liquid chromatographyPmass spectrometry (LCPMS) will play an important role in chemistry and DMPK studies of traditional Chinese medicine. The chemical fingerprints of traditional Chinese medicines should be correlated with their pharmacological activities so as to establish a reasonable traditional Chinese medicine quality evaluation system. Structural modification could be valuable for natural product-based drug discovery.

Contents
1  Introduction
2  Studies on the traditional Chinese medicine Chan-Su (toad venom)
2. 1  Chemical constituents of toad venom
2. 2  Chemical fingerprint of toad venom and peak interpretation
2. 3  Quantitative analysis of major bufadienolides in toad venom
2. 4  In vivo metabolism of toad venom
2. 5  Structural modification of bufadienolides
3  Perspectives
3. 1  How to study the chemistry of traditional Chinese medicines ?
3. 2  How to establish the chemical fingerprint of traditional Chinese medicines ?
3. 3  How to study the DMPK of traditional Chinese medicines ?
3. 4  How to do the structural modification of natural products ?
4  Conclusions

中图分类号: 

()

[ 1 ]  Ye M, Guo H , Guo H Z, et al . J . Chromatogr. B , 2006 , 838 (2) :86 —95
[ 2 ]  Ye M, Guo D A. Rapid Commun. Mass Spectrom. , 2005 , 19 (13) :1881 —1892
[ 3 ]  Liang Y, Liu A H , Qin S , et al . J . Pharm. Biomed. Anal . , 2008 ,46 : 442 —448
[ 4 ]  Ye M, Dai J G, Guo H Z, et al . Tetrahedron Lett . , 2002 , 43(47) : 8535 —8538
[ 5 ]  Ye M, Han J , Guo H Z, et al . Magn. Reson. Chem. , 2002 , 40(12) : 786 —788
[ 6 ]  Ye M, Ning L L , Zhan J X, et al . J . Mol . Catal . B : Enzym. ,2003 , 22 (1P2) : 89 —95
[ 7 ]  Ye M, Han J , Tu G Z, et al . J . Nat . Prod. , 2005 , 68 ( 4) :626 —628
[ 8 ]  Ye M, Han J , An D G, et al . Tetrahedron , 2005 , 61 ( 37) :8947 —8955
[ 9 ]  Ye M, Guo D A. Nat . Prod. Res. , 2008 , 22 (1) : 26 —30
[10 ]  Ye M, Qu GQ , Guo H Z, et al . Appl . Environ. Microbiol . , 2004 ,70 (6) : 3521 —3527
[11 ]  Ye M, Guo D A. J . Biotechnol . , 2005 , 117 (3) : 253 —262
[12 ]  Ye M, Qu GQ , Guo H Z, et al . J . Steroid Biochem. Mol . Biol . ,2004 , 91 (1P2) : 87 —98
[13 ]  Ye M, Yan Y N , Guo D A , et al . Rapid Commun. Mass Spectrom. , 2005 , 19 (11) : 1469 —1484
[14 ]  Ye M, Han J , Chen H B , et al . J . Am. Soc. Mass Spectrom. ,2007 , 18 (1) : 82 —91
[15 ]  Ye M, Guo D A , Ye G, et al . J . Am. Soc. Mass Spectrom. ,2005 , 16 (2) : 234 —243
[16 ]  Ma X C , Cui J , Zheng J , et al . J . Mol . Catal . B : Enzym. , 2007 ,48 : 42 —50

[1] 何静, 陈佳, 邱洪灯. 中药碳点的合成及其在生物成像和医学治疗方面的应用[J]. 化学进展, 2023, 35(5): 655-682.
[2] 苏正元, 舒利民, Jong Hun Lee, Franciso Fuentes, 王虎, 吴天元, 余四旺, Ah-Ng Tony Kong. 食用植物成分和中药用于癌症化学预防:Nrf2,表观基因组学,癌症干细胞[J]. 化学进展, 2013, 25(09): 1526-1543.
[3] 王嫣, 尤明. 增生平用于口腔癌化学预防[J]. 化学进展, 2013, 25(09): 1594-1600.
[4] 陈洪章*, 彭小伟. 汽爆技术促进中药资源高值化利用[J]. 化学进展, 2012, (9): 1857-1864.
[5] 蔡宝昌, 秦昆明, 吴皓, 蔡皓, 陆兔林, 张兴德. 中药炮制过程化学机理研究[J]. 化学进展, 2012, 24(04): 637-649.
[6] 吴毓林. 青蒿素——历史和现实的启示[J]. 化学进展, 2009, 21(11): 2365-2371.
[7] 叶晓川,杨祥良,徐辉碧. 纳米雄黄研究进展[J]. 化学进展, 2009, 21(05): 934-939.
[8] 陈振锋,彭艳,谭明雄,刘延成,王恒山,梁宏. 基于中药活性成分的金属基抗肿瘤药物前期研究*[J]. 化学进展, 2009, 21(05): 929-933.
[9] 姚新生,叶文才,栗原博. 阐明中药科学内涵 推进中药现代化与创新药物研究进程[J]. 化学进展, 2009, 21(01): 2-13.
[10] 徐强,孙洋. 源于中药选择性效应的新型免疫抑制疗法[J]. 化学进展, 2009, 21(01): 55-62.
[11] 王锋鹏. 从草乌化学研究开发的新药思考中药现代化的方法[J]. 化学进展, 2009, 21(01): 63-65.
[12] 朱大元. 中药活性成分研究是中药现代化的重要组成部分[J]. 化学进展, 2009, 21(01): 24-29.
[13] 孙汉董,赵勤实. 防治心脑血管疾病药物——灯盏细辛酚的研究与开发[J]. 化学进展, 2009, 21(01): 77-83.
[14] 闫瑾,赵美萍,李元宗,常文保. 罂粟碱检测方法研究进展*[J]. 化学进展, 2005, 17(05): 897-904.
[15] 何祥久,邱峰,姚新生. 中药复方研究现状和思路[J]. 化学进展, 2001, 13(06): 481-.